A photobleaching-based PDT dose metric predicts PDT efficacy over certain BPD concentration ranges in a three-dimensional model of ovarian cancer

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 8568, Issue , 2013, Pages

  Anbil, S ^a   Rizvi, I ^a   Celli, J P ^b   Alagic, N ^a   Hasan, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Implicit dosimetry; Ovarian Cancer; PDT dose metric; photobleaching; Photodynamic Therapy; Three dimensional model

Indexed keywords

CONCENTRATION RANGES; DOSIMETRIC PARAMETER; OVARIAN CANCERS; PDT DOSE METRIC; PHOTODYNAMIC THERAPY (PDT); THREE-DIMENSIONAL (3D) MODEL; THREE-DIMENSIONAL MODEL; TREATMENT OUTCOMES;

DISEASES; DOSIMETRY; PHOTOBLEACHING; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; TUMORS;

THREE DIMENSIONAL;

EID: 84878128581     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.2010840     Document Type: Conference Paper

References (13)

1. Celli, J. P., B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue, and T. Hasan, Imaging and photodynamic therapy: mechanisms, monitoring, and optimization, Chem Rev, 110(5), 2795-838 (2010).
2. Rizvi, I., S. Anbil, N. Alagic, J. P. Cell, L. Z. Zheng, A. Palanisami, M. D. Glidden, B. W. Pogue, and T. Hasan, PDT Dose Parameters Impact Tumoricidal Durability and Cell Death Pathways in a 3D Ovarian Cancer Model, Photochemistry and Photobiology, n/a-n/a (2013).
3. Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, and J. Golab, Photodynamic therapy of cancer: an update, CA Cancer J Clin, 61(4), 250-81 (2011).
4. Huang, Z., A review of progress in clinical photodynamic therapy, Technol Cancer Res Treat, 4(3), 283-93 (2005).
5. Wilson, B. C., M. S. Patterson, and L. Lilge, Implicit and explicit dosimetry in photodynamic therapy: a New paradigm, Lasers in medical science, 12(3), 182-99 (1997).
6. Weston, M., and M. Patterson, Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival, Photochemistry and photobiology, 87(36ede0d1-8fce-fbe3-8636-a5f55e11a5d6), 1129-1166 (2011).
7. Jarvi, M., M. Niedre, M. Patterson, and B. Wilson, Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects, Photochemistry and photobiology, 82(5), 1198-1210 (2006).
8. Leblond, F., S. C. Davis, P. A. Valdes, and B. W. Pogue, Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications, J Photochem Photobiol B, 98(1), 77-94 (2010).
9. Ascencio, M., P. Collinet, M. O. Farine, and S. Mordon, Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy, Lasers Surg Med, 40(5), 332-41 (2008).
10. Dysart, J. S., G. Singh, and M. S. Patterson, Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells, Photochemistry and photobiology, 81(1), 196-205 (2005).
11. Dysart, J. S., and M. S. Patterson, Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro, Physics in medicine and biology, 50(11), 2597- 616 (2005).
12. Glidden, M. D., J. P. Celli, I. Massodi, I. Rizvi, B. W. Pogue, and T. Hasan, Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters, Theranostics, 2(9), 827-39 (2012).
13. Zhou, X., B. W. Pogue, B. Chen, E. Demidenko, R. Joshi, J. Hoopes, and T. Hasan, Pretreatment photosensitizer dosimetry reduces variation in tumor response, Int J Radiat Oncol Biol Phys, 64(4), 1211-20 (2006).